Opinion - (2025) Volume 11, Issue 1
Received: 28-Jan-2025, Manuscript No. cdp-25-165820;
Editor assigned: 30-Jan-2025, Pre QC No. P-165820;
Reviewed: 13-Feb-2025, QC No. Q-165820;
Revised: 20-Feb-2025, Manuscript No. R-165820;
Published:
27-Feb-2025
, DOI: 10.37421/2572-0791.2025.11.159
Citation: Caolina, Diax. "Cognitive and Emotional Effects of tDCS in Depressed vs. Non-depressed Individuals: A Comparative fMRI Study." Clin Depress 11 (2025): 159.
Copyright: © 2025 Caolina D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
tDCS is a non-invasive neuromodulation technique that applies a low-intensity electrical current to specific regions of the brain via electrodes placed on the scalp. The goal of tDCS is to modulate neuronal excitability in targeted brain areas, which has been shown to have therapeutic effects for a range of neurological and psychiatric conditions, including depression. In particular, the Dorsolateral Prefrontal Cortex (DLPFC) has been a frequent target of tDCS studies in the context of depression. The left DLPFC, in particular, has been associated with positive affect regulation and cognitive control, while the right DLPFC has been linked to the regulation of negative emotions. In individuals with MDD, decreased activity in the left DLPFC and increased activity in the right DLPFC are frequently observed, and these neural abnormalities are thought to contribute to the cognitive and emotional symptoms of the disorder. By applying anodal stimulation to the left DLPFC and cathodal stimulation to the right DLPFC, tDCS aims to rebalance the neural activity in these areas, potentially improving both cognitive performance and emotional regulation [2].
Despite the growing body of evidence supporting the use of tDCS for depression, the mechanisms underlying its effects remain only partially understood. The role of tDCS in modulating cognition and emotion in individuals with depression, compared to healthy individuals, has not been thoroughly explored. One particularly useful tool for examining these mechanisms is functional Magnetic Resonance Imaging (fMRI), which allows for the non-invasive measurement of brain activity during cognitive and emotional tasks. fMRI studies have provided valuable insights into how tDCS affects brain function in depressed versus non-depressed individuals, shedding light on the differential impacts of this neuromodulation technique across varying psychiatric conditions. In this context, comparative studies using fMRI to explore the cognitive and emotional effects of tDCS in both depressed and non-depressed individuals could offer important insights into its therapeutic potential and guide its clinical application [3].
This research article explores the cognitive and emotional effects of tDCS in depressed and non-depressed individuals, with a focus on understanding the differential neural responses to tDCS. By utilizing fMRI as a primary tool, this study aims to investigate how tDCS influences brain activity in response to cognitive and emotional tasks in both groups. Specifically, we aim to examine how tDCS affects areas of the brain involved in emotion regulation, such as the prefrontal cortex and limbic structures, and cognitive processes like attention, memory, and executive function. Furthermore, by comparing the effects of tDCS in depressed and non-depressed individuals, this research seeks to elucidate whether tDCS produces similar or divergent neural changes across different populations and whether these effects correlate with improvements in mood and cognitive functioning [4,5].
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Clinical Depression received 89 citations as per Google Scholar report